Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
In all but two U.S. states, stay-at-home orders are being lifted, and businesses are reopening. But can the lifting of restrictions be safe, when COVID-19 is still increasing in many parts of the country? Atul Gawande, a surgeon at Brigham…
Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected -- especially those…
Science correspondent Miles O’Brien has spent the past few weeks in Seattle, reporting on the COVID-19 pandemic and producing a film for FRONTLINE about how things unfolded in the city where the disease made its U.S. debut. He joins William…
By Cat Wise
Dorms are empty and classroom lights are off at the vast majority of America’s colleges and universities, but that hasn’t stopped many in academia from jumping in to help.
By Judy Woodruff, Courtney Vinopal, Courtney Norris
Microsoft co-founder Bill Gates has spent the last few decades working to improve global health through his philanthropic organization, the Bill & Melinda Gates Foundation. One area of focus has been reducing the spread of infectious disease -- a mission…
By Nsikan Akpan, Vanessa Dennis
PBS NewsHour breaks down the U.S. fall and rise of the measles in 3 charts.
By Nsikan Akpan
A new study reminds us of how much vaccine effectiveness hinges on one thing: our personal genetics.
By David Klepper, Associated Press
The law takes effect immediately but will give unvaccinated students up to 30 days after they enter a school to show they've had the first dose of each required immunization.
By Mike Stobbe, Associated Press
Cases have surged again, and are on pace to set a record for most illnesses in 25 years.
By Barbara Ortutay, Associated Press
In social media's battle against misinformation, bogus claims about the dangers of vaccines are the next target.
Support Provided By:
Additional Support Provided By: